One smash IPO does not a recovery make

[Joelle]

One smash IPO does not a recovery make
      

If one didn’t know better, one could think all was all right in the world of IPOs right now.
Mead Johnson, the kids’ nutrition unit of pharma giant Bristol Myers Squibb, scored a home run with its IPO this week, raising $720 million and selling 5 million more shares than expected. The stock has enjoyed a [...]
         

You are not allowed to view links. Register or Login